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Long-term stability and biological safety are crucial for translation of 3D-bioprinting
technology into clinical applications. Here, we addressed the long-term safety and
stability issues associated with 3D-bioprinted constructs comprising a cellulose scaf-
fold and human cells (chondrocytes and stem cells) over a period of 10 months in
nude mice. Our findings showed that increasing unconfined compression strength
over time significantly improved the mechanical stability of the cell-containing con-
structs relative to cell-free scaffolds. Additionally, the cell-free constructs exhibited a
mean compressive stress and stiffness (compressive modulus) of 0.04 ± 0.05 MPa
and 0.14 ± 0.18 MPa, respectively, whereas these values for the cell-containing con-
structs were 0.11 ± 0.08 MPa (p = .019) and 0.53 ± 0.59 MPa (p = .012), respectively.
Moreover, histomorphologic analysis revealed that cartilage formed from the cell-
containing constructs harbored an abundance of proliferating chondrocytes in clus-
ters, and after 10 months, resembled native cartilage. Furthermore, extension of the
experiment over the complete lifecycle of the animal model revealed no signs of
ossification, fibrosis, necrosis, or implant-related tumor development in the 3D-bio-
printed constructs. These findings confirm the in vivo biological safety and mechani-
cal stability of 3D-bioprinted cartilaginous tissues and support their potential
translation into clinical applications.
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1 | INTRODUCTION
Long-term stability and mechanical resilience are key features of carti-
laginous tissue used in reconstructive surgery and that enable their
sustainment of configuration/shape and elasticity characteristics. Cur-
rent methods involve transposing autologous cartilaginous tissue from
one site to another in order to reconstruct deformities; however, this
technique often leads to significant donor-site morbidity and variable
esthetic results (Firmin, 2010; Firmin & Marchac, 2011; Osorno, 1999;
Zopf, Iams, Kim, Baker, & Moyer, 2013). Previous studies described
methods for creating cartilaginous tissue using three-dimensional
(3D)-bioprinting technology and stem cells; however, all of these
methods raise concerns regarding the behavior of neocartilage over
time in terms of mechanical features and safety (DeForest &
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Anseth, 2012; Mouser et al., 2017; You, Eames, & Chen, 2017). For
example, cartilage-like tissue can potentially be resorbed, transform
into bone, or potentially become carcinogenic (de Vries et al., 2008;
Gilbert, O'Connell, Mladenovska, & Dodds, 2018; Hyun, 2010). There-
fore, translation of this method to clinical use in humans requires fur-
ther investigation of its safety and the associated ethical issues
(Hyun, 2010).
Native human hyaline cartilage displays several mechanical features
that define its physiological function. Compressive stress is related to
the ability of tissues to withstand compressive pressure, and in articular
cartilage (i.e., hyaline cartilage), this represents the primary function
involved in absorbing compressive forces. However, the primary func-
tions of elastic cartilage are defined according to its elasticity and
shape-retaining features. In addition to chondrocytes, which constitute
~2% (wet weight) of articular cartilage, mature human cartilage tissue
mainly comprises water (up to 80% of its wet weight), collagen, and
proteoglycans (Carballo, Nakagawa, Sekiya, & Rodeo, 2017; Sophia Fox,
Bedi, & Rodeo, 2009). Chondrocytes originate from mesenchymal stem
cells (MSCs), with the addition of MSCs to mixtures of adult cho-
ndrocytes enhancing their proliferative capacity via paracrine signaling
associated with chondrogenesis that occurs during 3D bioprinting
(Apelgren et al., 2017; FDA Public Hearing on Regulation of Stem
Cells, 2016; Moller et al., 2017). Given the numerous studies verifying
this process, addition of MSCs to promote this activity can be consid-
ered the gold standard for 3D-bioprinting technology (Aung, Gupta,
Majid, & Varghese, 2011; Bigdeli et al., 2009; de Windt et al., 2014;
Grimaud, Heymann, & Redini, 2002; Lettry et al., 2010; Mo et al., 2009;
Wu, Leijten, van Blitterswijk, & Karperien, 2013).
Because harvesting MSCs from bone marrow is highly invasive
and yields a rather small proportion of stem cells, previous studies eval-
uated other sources of autologous stem cells. A review by de Windt
et al. (de Windt et al., 2014) summarising key studies between 2007
and 2014 noted the use of adipose tissue and, more specifically, a frac-
tion of the lipoaspirate called the stromal vascular fraction (SVF) as
sources of stem cells. Compared with MSCs, stem cells derived from
the SVF can be more easily harvested in large amounts (e.g., liposuc-
tion) and isolated without the need for in vitro culture. Additionally,
the SVF contains other types of supporting precursor cells, such as
pericytes (Faustini et al., 2010; Jang et al., 2015; Rehman et al., 2004).
Cellulose is a beneficial scaffolding biomaterial, with previous stud-
ies confirming its advantageous biocompatibility profile (Pertile
et al., 2012; Petersen & Gatenholm, 2011), and the Food and
Drug Administration having approved its use in human medical
applications. Moreover, cellulose is non-biodegradable and, therefore,
promotes retention of the desired shape and mechanical features of
3D-bioprinted constructs over time. Additionally, this characteristic
minimizes the release of potentially unfavorable degradation
byproducts, thereby ensuring the inert nature of the scaffolding mate-
rial supporting the autologous cells and precluding an immune response
to the graft. A previous study evaluating 3D-bioprinted constructs in
mice reported that cellulose implants caused a mild and transient
inflammatory response but without any foreign-body response (Pertile
et al., 2012). However, although the nude mice used in that study were
T cell-deficient, it is possible that the cellulose could have potentially
generated a humoral (i.e., B cell-mediated) immune response.
2 | MATERIALS AND METHODS
2.1 | Cell types and culture
Human bone-marrow-derived MSCs originally obtained from female
donors (age range: 18–30 years; Rooster Bio, Frederick, MD) were
cultured under standard culture conditions (37C and 5% CO2) using
an MSC high-performance media kit (Rooster Bio).
Human nasoseptal cartilage biopsies were obtained from male
donors (age range: 24–40 years; average: 34 ± 5.97 [n = 6]) during rou-
tine surgery (i.e., septoplasties or septorhinoplasties) at the Department
of Otorhinolaryngology, Head and Neck Surgery, Charité-Medical Uni-
versity (Berlin, Germany). Cartilage harvesting was approved by the
University of Berlin Ethics Committee (Dnr EA1/169_12), and all
patients provided written informed consent. All cartilage samples were
first rinsed in sterile 0.1 M phosphate-buffered saline (PBS) and subse-
quently in standard culture medium (Dulbecco's modified Eagle
medium/F-12 (DMEM; 1:1; Life Technologies, Waltham, MA) sup-
plemented with 10% fetal bovine serum (FBS; HyClone; GE Healthcare,
South Logan, UT) and 1% penicillin/streptomycin [P/S; Biochrom,
Holliston, MA]) under sterile conditions. Adherent non-cartilaginous tis-
sues, including the perichondrium and epithelium, were removed.
To isolate human primary nasal chondrocytes (hNCs), cartilage sam-
ples were sliced into 1 mm × 1 mm pieces, and after discarding the
medium, transferred to pronase (Serva, Heidelberg, Germany) digestion
solution (10 ml; 20 mg/ml [2%] pronase in DMEM supplemented with
1% P/S without FBS). For the first round of pronase digestion, samples
were incubated at 37C and 5% CO2 for 45 to 60 min under continu-
ous agitation, after which the pronase solution was discarded, and pre-
digested cartilage samples were washed twice with sterile 1× PBS. For
the final digestion, cartilage samples were transferred to collagenase
(Gibco; Life Technologies) digestion solution [1 mg/ml (0.1%) collage-
nase in DMEM complemented with 0.5% FBS and 1% P/S] and incu-
bated for 16 to 18 hr at 37C and 5% CO2 with continuous shaking.
After centrifugation, total cell number and viability were determined
using the Trypan blue exclusion method (Table S1). Subsequently, hNCs
were seeded for amplification at an initial density of 5 × 103 cells/cm2
and cultured in standard culture medium. Upon reaching 80 to 90%
confluence, cells were detached, counted (Cell Counter; Thermo Fisher
Scientific, Waltham, MA), and cryopreserved to ensure equal treatment
of all hNCs harvested from different patients. Cryopreserved hNCs and
MSCs were thawed and expanded once in monolayer culture to obtain
a sufficient number of cells. Upon reaching 80 to 90% confluence, cells
were detached, counted, and resuspended in standard culture medium
before mixing with nanofibrillated cellulose/alginate (NFC-A) bioink
(CELLINK AB, Gothenburg, Sweden). All experiments were conducted
using hNCs and MSCs at passage two.
The SVF was isolated from abdominal lipoaspirate from a female
donor according to the protocol described by Zhu et al. (Zhu
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et al., 2013). The lipoaspirate was harvested at Art Clinic AB (Gothen-
burg, Sweden) during an elective cosmetic procedure and processed
to extract the SVF after obtaining written consent from the patient.
The use of surgical residuals from humans (i.e., lipoaspirate) was
approved by the Regional Ethical Committee (Göteborg, Sweden; Dnr
624-16). Briefly, the adipose layer was separated from the
lipoaspirate, and the infranatant, containing mostly saline and red
blood cells, was discarded. The adipose tissue was then washed with
sterile PBS until the adipose layer showed a yellow/gold color, after
which it was incubated with an equal volume of sterile 0.075% colla-
genase 1A (Gibco; Life Technologies) for 30 min at 37C, during which
time the adipose fraction/collagenase mixture was gently swirled
every 5 to 10 min to ensure complete digestion. The infranatant con-
taining the SVF was transferred to 50-ml centrifuge tubes, and an
equal amount of standard culture medium was added to inactivate the
collagenase, followed by centrifugation for 10 min at 1200g to collect
the SVF as a pellet. Red blood cells were lysed with H2O for 15 s,
followed by the addition of PBS to the samples and centrifugation.
The SVF pellet was then resuspended in standard culture medium,
and the number of cells was determined before printing. The number
of cells added to the bioink was calculated from the living-cell fraction
obtained from the cell counter (Table S1).
2.2 | Animals
We used female, nude Balb/C mice (n = 22; 8-weeks old; Scanbur,
Karlslunde, Denmark). European husbandry regulations were followed,
as were national and local regulations. The study was approved by the
Ethical Committee for Animal Experiments at Sahlgrenska University
Hospital/Gothenburg University (Göteborg, Sweden; Dnr 36-2016).
2.3 | Bioink and 3D bioprinting
Cells were mixed with NFC-A bioink (CELLINK AB) at a ratio of 1:11,
with the initial cell density for all groups at 1 × 106 cells/ml bioink and
a cell ratio of 20% hNCs and 80% MSCs or SVF (i.e., SVF-derived stem
cells). A 6 mm × 6 mm × 1.2 mm grid was printed using a pneumatic
extrusion 3D bioprinter (INKREDIBLE; CELLINK AB) under laminar
airflow. Bioprinting pressure in Table S2. After printing, constructs
were cross-linked with 100 mM CaCl2 solution for 5 min and washed
in standard culture medium, followed by implantation into nude mice
within 1 hr after printing. For day 0, printed constructs were directly
fixed in 4% paraformaldehyde (PFA) supplemented with 20 mM
CaCl2.
2.4 | Experimental design
The animals were divided in three groups: (a) a control group implanted
with cell-free constructs, (b) a group implanted with a mixture of hNCs
and MSCs, and (c) a group implanted with a mixture of hNCs and SVF
(Table 1). For general anaesthesia, each animal received 0.04 ml of the
anaesthetic solution (50 mg/ml ketamine and 1 mg/ml medetomidine at
a 1:1 ratio) per 20 g body weight via intraperitoneal injection, and the
3D-bioprinted constructs were surgically implanted subcutaneously on
the back, followed by closure of the skin pockets with sutures (Vicryl
Rapid; Ethicon, Sommerville, NJ, USA). After 8 months and 10 months,
respectively, the constructs were harvested, fixed in 4% PFA sup-
plemented with 20 mM CaCl2 overnight at 4C, and embedded in paraf-
fin. The chosen time frame was determined based on the expected
lifespan for this animal model (i.e., 6–12 months) (Anisimov et al., 2001;
Brayton, Treuting, & Ward, 2012; Piantanelli et al., 2001).
2.5 | Biomechanical analysis
The mechanical properties of the scaffolds were assessed after printing,
as well as after 8 months and 10 months for the implanted constructs,
using a universal testing machine (Model 5565A; Instron, Norwood, MA,)
equipped with a 10-N load cell and a cylindrical plane-ended stainless-
steel indenter (Ø: 12 mm). Unconfined compression tests were
performed on wet samples at room temperature. Photographs of the
samples before testing were acquired and used to determine the initial
dimensions of the samples by measuring the area using ImageJ software
(National Institutes of Health, Bethesda, MD). Samples were compressed
at intervals of 1% per s (1.08 mm/min) until reaching a 40% compressive
strain. Maximum compressive stress at a 40% compressive strain and the
tangent modulus at 20 and 30% compressive strain, respectively, were
calculated for all samples based on the measured area of each sample.
2.6 | Morphological analysis
The outer millimeter on each side of the sample was discarded, and the
paraffinized core sections (5-μm thick) were scanned using a Nikon
Eclipse 90i epi-fluorescence microscope equipped with a Nikon DS-Fi2
color head camera (Nikon Instruments, Melville, NY) and the NIS-Ele-
ments imaging software suite (v.D4.10.02; Nikon Instruments).
Glycosaminoglycan (GAG) production by chondrocytes was visualized
with Alcian blue and van Gieson staining, and Safranin-O was used to
determine the presence of proteoglycans. Each nucleus surrounded by a
blue-stained extracellular matrix was counted manually, with the total
TABLE 1 Experimental design and composition of the 3D constructs
Group Cell type Cell composition 8 months (n) 10 months (n)
1 Cell-free — 3 3
2 Mix 1 20% hNCs, 80% MSCsa 4 4
3 Mix 2 20% hNCs, 80% SVFa 4 4
a1 × 106 cells/ml.
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number of chondrocytes relative to that in the area of each section
determined using PhotoShop (CC 2018, Adobe Systems, San Jose, CA).
2.7 | Statistical analysis
A Mann–Whitney U test was used. All statistical calculations were




The NFC-A scaffolds, both with cells and cell-free blanks, were
printed with high levels of printing fidelity and exhibited good print-
ability and dimensional stability. A majority of the cell-containing con-
structs retained their macroscopic integrity and structural properties
and were surgically easy to handle at explantation, whereas the cell-
free constructs displayed increased fragility and teared more easily
when handled surgically.
3.2 | Animals
In total, 20 of 22 mice survived the entire study period, with one
mouse in group 2 dying of unknown cause after 6 months, and
another mouse in group 3 requiring premature euthanasia (after
7 months) due to abdominal swelling. Autopsy of the mouse with the
abdominal swelling revealed ascites and a prominent
hepatosplenomegaly, with histopathologic analysis of tissue samples
indicating findings consistent with high-grade lymphoma. Additionally,
after ~7 months, some mice exhibited scratch behaviour and eventu-
ally developed ulcerations on their backs, which was considered asso-
ciated with an unspecific skin condition and not grounds to
prematurely abort the study. The mice displaying these ulcerations
(n = 5) were subsequently transferred to the subgroups used for the
8-month time point. During explantation, one animal from this group
of transferred mice underwent intraabdominal examination for
suspected abdominal swelling, revealing an enlarged spleen and a con-
spicuous tumor in the left groin, with histopathologic analysis consis-
tent with high-grade lymphoma. The remaining animals (n = 10)
completed the 10-month experiment without issue.
3.3 | Chondrogenesis and chondrocyte
proliferation
In the hNC/MSC group, we measured 140.3 ± 67.4 chondrocytes/
mm2 after 8 months and 87.9 ± 62.7 chondrocytes/mm2 after
10 months (p = .30), whereas in the hNC/SVF group, these values
were 59.4 ± 35.6 chondrocytes/mm2 and 31.7 ± 21.5 chondrocytes/
mm2, respectively (p = .09). We observed no significant difference
between the two groups at either 8 months or 10 months (p = .052
and p = .2, respectively), and no chondrocytes were found in the cell-
free constructs (Figures 1 to 3).
3.4 | Biomechanical analysis
The implanted scaffolds were prepared for mechanical testing and
used for calculation of the cross-section area for each sample. The
shape of the samples was uneven and varied (from circular to rectan-
gular), as did the porosity and visible grid structure along with the
presence of attached tissue following sample preparation. Addition-
ally, we observed large variations in the measured mechanical proper-
ties (compressive stress at 40% strain and compressive modulus at
30% strain). Pooling of the cell-containing constructs and comparison
with the cell-free constructs revealed a significant difference in mean
compressive stress (cell-free constructs, 0.04 ± 0.05 MPa vs. cell-con-
taining constructs, 0.11 ± 0.08 MPa [p = .019]) and stiffness (com-
pressive modulus: 0.14 ± 0.18 MPa vs. 0.53 ± 0.59 MPa, respectively
[p = .012]) (Figure 4). However, no significant difference was observed
between the two different cell-containing groups or between the dif-
ferent time points (Figure S1).
4 | DISCUSSION
Rapid advancements in 3D-bioprinting technology support its even-
tual clinical application in reconstructive surgery; however, several
issues remain unresolved. These include the lack of data concerning
the long-term in vivo status of transplanted constructs in order to
address safety concerns, such as the risk of ossification, neoplasm
F IGURE 1 Determination of glycosaminoglycan (GAG) production
in chondrocytes. The number of GAG-positive chondrocytes after 8
and 10 months, respectively. Although a slight decrease was observed
in cell density between the two time points, there was no significant
difference between the two stem cell sources (hNC/MSC vs.
hNC/SVF)
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development, and material resilience and shape stability. Additionally,
the optimal cell-progenitor composition necessary for chondrogenesis
has yet to be established and evaluated.
In this study, we evaluated the long-term outcomes on cho-
ndrogenesis associated with transplanted 3D-bioprinted constructs,
with the results suggesting that constructs containing cells were more
stable over time. Moreover, we observed survival and proliferation of
the transplanted human chondrocytes accompanied by formation of
cartilage-like tissues, with their survival limited only by the longevity
of the animal model used. Furthermore, over the 10-month study
F IGURE 2 Histologic analysis of the three groups. Each group was stained with (a) both Alcian blue and van Gieson and (b) Safranin-O.
Mixtures of hNC/MSCs after (a) 8 months and (c) 10 months, respectively. (b) Cell-free construct after 8 months. Mixtures of hNC/SVF after (d)
8 months and (e) 10 months, respectively. Bars = 500 μm
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period, we observed no adverse events, such as neoplasms, ossifica-
tion, or necrosis.
Mechanical assessment of the constructs revealed that the cell-
containing constructs exhibited greater resilience and robustness over
time relative to the cell-free constructs. Measurement of compressive
stress allows determination of the force required to deform a sample
to a certain percentage (at 40% strain, the sample is compressed to
40% of its initial height), whereas measurement of stiffness (modulus)
indicates how well a sample resists elastic deformation while being
compressed. Mechanical testing over the 8- and 10-month evaluation
of the 3D-bioprinted grids following implantation is challenging, as
the grid dimensions vary between samples due to their lack of homo-
geneity, with this primarily concerning the variable content of connec-
tive tissue stuck to the grids, which in turn influences mechanical
properties and results in large variance in the measurements. Our
findings indicated that the mechanical properties of the constructs
were comparable with native human cartilage. The mechanical data
were comparable to findings reported previously regarding cell-free
samples prepared with similar scaffold material (cellulose and alginate)
(compressive stress at 30% strain: 0.032 ± 0.005 MPa; and compres-
sive stiffness at 30% strain: 0.15 ± 0.05 MPa) (Markstedt et al., 2015;
Nimeskern et al., 2013).
F IGURE 3 Histological section
from the hNC/MSC group after
8 months. Bar = 500 μm. Magnification
shows two chondrocyte clusters
(bar = 100 μm)
F IGURE 4 Comparison of cell-
free constructs with cell-containing
constructs (hNC/MSC vs. hNC/SVF).
Compressive stress at 40% strain (left)
and compressive modulus (stiffness) at
30% strain (right)
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After 10 months, we observed a large population of viable cho-
ndrocytes, with the overall chondrocyte cell count and clustering in
the hNC/MSC and hNC/SVF constructs indicating similarities with
those of native cartilage. In mature human cartilage, the number of
chondrocytes in weight-bearing, hyaline cartilage is ~90 cho-
ndrocytes/mm2, with this number declining rapidly with age (Bobacz,
Erlacher, Smolen, Soleiman, & Graninger, 2004). The mean cell count
in the present study was ~100 chondrocytes/mm2 at 8 months
and ~ 60 chondrocytes/mm2 at 10 months, suggesting an age-related
decline in our model. Moreover, histologic analysis confirmed the
presence of features in the 3D-bioprined cartilage resembling those
of human cartilage. Based on the results from a previous study using
FISH analysis, the proliferating chondrocytes originates from the adult
chondrocytes, and not from the stem cells (Apelgren et al., 2017).
Our results indicated that SVF-derived stem cells exerted quanti-
tatively similar trophic effects on chondrocyte proliferation to those
observed using bone-marrow-derived MSCs. Specifically, we found
no significant difference in chondrogenesis between either of the two
cell-containing groups or the 8- and 10-month subgroups, regardless
of stem cell source. Previous studies reported the capacity of MSCs to
enhance chondrogenesis (Apelgren et al., 2017; Moller et al., 2017),
and Wu et al. (Wu et al., 2016) indicated that stem cells derived from
the SVF of adipose tissue showed and even greater capacity for pro-
moting chodrogenesis relative to that of MSCs (Wu et al., 2016). From
a clinical standpoint, the SVF is highly relevant because of the relative
ease associated with its harvesting process and the large amount of
stem cells that can be retrieved. Furthermore, the SVF does not
require in vitro manipulation or expansion prior to transplantation,
which potentially increases the ease of regulatory approval of the
entire procedure associated with autologous transplantation. We used
the specific 20/80 ratio (hNC/MSCs and hNC/SVF, respectively) as it
is well established to be an optimal ratio for induction of cartilage
regeneration (de Windt et al., 2014; Leijten et al., 2013; Martinez
Avila et al., 2015; Wu et al., 2011; Wu, Prins, Helder, van Blitterswijk,
& Karperien, 2012; Zuo et al., 2013).
The cell count and mechanical data showed that both hNC/MSCs
and hNC/SVF promoted the in vivo formation of similar native-like
cartilaginous tissue after 8 months. Further studies are required to
further discriminate MSCs from SVF-derived stem cells with regard to
how rapidly they create cartilage-like tissues. Because the SVF, similar
to adipose stem cells, contains intrinsic growth factors (e.g., pericytes
and other angiogenic building blocks) that surround cartilaginous tis-
sue and promote its proliferation (Rehman et al., 2004; Rubina
et al., 2009), use of an hNC/SVF mixture might represent a faster
method for cartilage regeneration.
Additionally, we histologically evaluated the conceivable transi-
tion to bone on the part of the two stem cell subsets, finding no indi-
cation of bone-tissue formation. The endochondral pathway involved
in bone formation uses chondrocytes as primary precursor cells but
requires systemic, as well as local, stimuli (growth factors), to activate
the necessary transcription factors. When activated at bone-forming
sites, chondrocytes withdraw, and vascularisation of the cartilage
extracellular matrix occurs accompanied by increases in osteocyte and
bone-marrow cell populations (Mackie, Ahmed, Tatarczuch, Chen, &
Mirams, 2008). In the present study, perseverance of the newly
formed cartilage tissue might be attributable to the lack of paracrine
signaling and trophic influence that trigger bone formation via the
endochondral pathway, thereby allowing the 3D-bioprinted structures
to retain their cartilaginous features (i.e., elasticity) over time.
Two mice in the hNC/SVF group exhibited tumors histopathologi-
cally resembling lymphoreticular neoplasms and, therefore, unrelated
to the chondrocyte lineage. According to previous studies, aging nude
mice are commonly afflicted by spontaneous lymphoreticular cancers
(Anisimov, 1987; Anisimov et al., 2001; Brayton et al., 2012; Bronson
& Lipman, 1993; Frith, 1983; Sharkey & Fogh, 1979; Storer, 1966).
Importantly, we found no neoplasms, such as sarcomas, conceivably
correlated with transplant of the 3D-bioprinted constructs.
Our study has limitations. Specifically, the lifespan of the animal
model used for in vivo evaluation is estimated at ~12 months; there-
fore, all the animals used in this study were close to this threshold
toward the end of our experimental assessment and exhibiting an
overall decline in physiological capability and resilience. Although
not significant, we observed declines in chondrocyte proliferation
according to cell count, which might have been associated with the
physiological limitations of the animal model rather than the
transplanted constructs. Future studies should focus on the use of
animal models providing a longer lifespan. Another major limitation
of the present study is the small number of animals in each group,
resulting in low statistical power and difficulties to detect
differences.
5 | CONCLUSIONS
This study showed that the 3D-bioprinted constructs containing
chondrocytes and stem cells effectively created viable and mechani-
cally stable cartilage-like tissues over a 10-month period in a mouse
model. Importantly, we observed no adverse effects following trans-
plantation, such as engraftment-related neoplasms, ossification, or
necrosis, over the lifespan of the animals. These results confirmed
the clinical efficacy of 3D-bioprinting technology and encourage fur-
ther trials using immunocompetent animal models (e.g., pigs) and
humans.
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